
Please try another search
SAN DIEGO – Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biopharmaceutical company with a market capitalization of $296 million and trading near its 52-week high of $28.42, reported significant...
Cidara Therapeutics Inc . (NASDAQ:CDTX) stock has reached a remarkable 52-week high, touching $24.99 in recent trading. With a market capitalization of $272 million, the company maintains a healthy...
Cidara Therapeutics (NASDAQ:CDTX) has filed for up to 7,041,309 share offering by selling stockholders.
Cidara Therapeutics Inc . (NASDAQ:CDTX) stock has reached a remarkable 52-week high, touching $24.4 amidst a period of significant growth. With a market capitalization of $262.31 million,...
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC)...
SAN DIEGO - Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology firm specializing in immunotherapies, has disclosed a securities purchase agreement to raise approximately $105 million through a...
Cidara Therapeutics, Inc. (Nasdaq: NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and...
SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC)...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review